|
Overall Morningstar
Rating™ |
| What is this? |
 |
 |
| As of 2009-10-31 |
|
Out of
Health Funds |
|
| Rating derived from a weighted average of the fund's 3, 5, 10-year rating which are based on risk-adjusted performance. |
|
|
|
Morningstar®
Style Box™ |
| What is this? |
|
 |
|
Large |
|
|
Growth |
|
|
|
|
|
|
|
|
| As of
2009-06-30 |
|
|
| Day Change |
| $ 0.00 |
|
|
| NAV (2009-11-20) |
| $ 26.50 |
|
|
| YTD Return % (2009-11-20) |
| 21.78% |
|
|
| Total Assets ($ mil) |
| 1,000 |
|
| Growth of $10,000 |
 |
Fund: |
BlackRock Health Sciences Ops Inv A LW |
| (from
1999-12-21
to 2009-10-31) |
 |
Category: |
Health |
|
 |
Index: |
S&P 500 TR |
| Total Annualized Returns % |
1yr, 3yr and 5yr Returns as of 2009-11-20 |
| Inception date: 1999-12-21 |
10yr and Inception Returns as of 2009-10-31 |
|
YTD Returns as of 2009-11-20 |
|
|
YTD |
1 Year |
3 Year |
5 Year |
10 Year |
Since Inception |
| Fund |
21.78 |
25.24 |
0.16 |
5.89 |
--- |
13.67 |
| +/- Category |
11.73 |
16.49 |
2.78 |
2.75 |
--- |
--- |
| +/- S&P 500 TR |
-1.74 |
-23.56 |
6.06 |
5.21 |
--- |
--- |
|
|
| Standardized Annual Returns % more on standardized returns |
| Quarter-End (as of
2009-09-30) |
18.11 |
1.61 |
5.31 |
10.07 |
--- |
14.10 |
| Month-End (as of 2009-10-31) |
15.07 |
13.06 |
3.84 |
9.84 |
--- |
13.67 |
|
|
| After Tax Returns % (as of
2009-09-30
)
|
| On Distribution |
--- |
10.66 |
2.70 |
8.90 |
--- |
--- |
| On Distribution & Sale of Shares |
--- |
9.53 |
2.85 |
8.15 |
--- |
--- |
|
|
| Morningstar Rating |
--- |
--- |
 |
|
--- |
--- |
|
| # of compared funds covered (3 yrs : out of 151 funds), (5 yrs : out of 143 funds), (10 yrs : out of funds). Ratings are based on risk-adjusted performance. The maximum initial sales fee is
none,
the maximum deferred sales fee is
none,
and the maximum redemption sales fee is
2.00%.
|
|
| The performance quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate thus an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted herein. |
|
|
|
|
| Sector Breakdown % |
|
 |
Information |
4.84 |
 |
Software |
2.07 |
 |
Hardware |
2.76 |
 |
Media |
0.00 |
 |
Telecommunications |
0.00 |
|
|
|
 |
Service |
94.47 |
 |
Healthcare |
84.83 |
 |
Consumer Services |
8.46 |
 |
Business Services |
1.18 |
 |
Financial Services |
0.00 |
|
|
|
 |
Manufacturing |
0.69 |
 |
Consumer Goods |
0.00 |
 |
Industrial Materials |
0.69 |
 |
Energy |
0.00 |
 |
Utilities |
0.00 |
|
|
|
|
| |
|
|
| Asset Allocation |
|
 |
|
| % of Net Assets |
 |
Cash |
6.7 |
 |
Stocks |
93.3 |
|
Bonds |
0.0 |
 |
Other |
0.0 |
|
|
|
Foreign Stocks |
18.4 |
|
(as a % of Assets) |
|
|
| Data through 2009-06-30 |
Data through 2009-06-30 |
 |
| Holding Status |
|
| Total Number of Stock Holdings |
79 |
|
Turnover % |
91 |
| Total Number of Bond Holdings |
0 |
|
30 Day SEC Yield % |
0.38 |
| % of Assets in Top 10 Holdings |
33.29 |
|
ending as of
2009-09-30 |
|
|
|
|
View Data Definitions |
| Top 10 Holdings |
Sector |
P/E |
YTD
Return % |
% of Net
Assets |
|
|
|
|
|
|
 |
Blackrock Liquidity Funds Tempfund Portfolio |
--- |
--- |
--- |
6.70 |
|
Wyeth |
|
--- |
--- |
6.27 |
|
CVS Caremark Corporation |
|
12.66 |
11.15 |
3.95 |
|
WellPoint, Inc. |
|
8.85 |
23.76 |
3.93 |
|
Alcon, Inc. |
|
13.14 |
66.79 |
3.37 |
|
 |
|
Pfizer Inc. |
|
14.88 |
8.19 |
3.14 |
 |
Amgen, Inc. |
|
14.81 |
-4.10 |
2.77 |
|
Medco Health Solutions, Inc. |
|
19.69 |
47.01 |
2.71 |
|
Roche Holding AG |
|
31.75 |
6.86 |
2.54 |
|
Becton, Dickinson and Company |
|
14.27 |
9.21 |
2.50 |
|
|
 |
Data through 2009-06-30 |
|
| YTD Return through 2009-11-20 |
|
|
| Fund Inception: 1999-12-21 |
|
Portfolio Manager (Start Date) |
|
|
|
|
|
Thomas P. Callan (2005-01-31) |
|
|
|
Callan, CFA, managing director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He is architect of the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. Prior to joining BlackRock in 1996, Callan was with the PNC Asset Mgmt Group, which he joined in 1992. Callan earned a BA degree in economics, with honors, from Boston College in 1981. |
|
|
|
|
|
Erin Xie (2003-07-31) |
|
|
|
Xie is the managing director and Portfolio Manager of BlackRock Advisor.Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999. |
|
|
|
|
Sales Charge %
(taken from prospectus dated 2009-01-28) |
| Front: |
None |
| Deferred: |
None |
|
| Expense Ratio % |
1.34 |
based on net assets
(taken from annual report dated 2008-09-30)
|
|
| Correspondence Information |
---
,
|
|
|
|
|
|
